FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to blood storage agents. Cryoprotector for whole blood freezing at low temperature -80 °C as initial ingredients contains, vol.%: glycerine 20, dimethyl sulphoxide 10, lactulose 10, sodium adenosine triphosphate 30, sterile 0.9% sodium chloride solution – up to 100%.
EFFECT: disclosed whole blood cryoprotectant provides blood storage at low temperatures with preservation of blood cell corpuscles in a physiologically active state after thawing.
1 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
WHOLE BLOOD CRYOPROTECTANT | 2023 |
|
RU2816446C1 |
CRYOPROTECTIVE SOLUTION FOR LEUKOCYTE FREEZING AT LOW TEMPERATURE | 2004 |
|
RU2290808C2 |
COMBINED CRYOPROTECTIVE SOLUTION FOR THROMBOCYTE FREEZING | 2012 |
|
RU2477953C1 |
METHOD FOR PRESERVING VIABILITY OF HEMATOPOIETIC STEM CELLS OF UMBILICAL BLOOD AFTER WASHING FROM CRYOPROTECTANT | 2023 |
|
RU2821586C1 |
METHOD FOR REDUCING TOXICITY OF CRYOPRESERVATION SOLUTION BASED ON DIMETHYL SULFOXIDE AFTER THAWING OF HEMATOPOIETIC STEM CELLS | 2020 |
|
RU2744614C1 |
CRYOPRESERVING AGENT FOR BLOOD NUCLEOCYTE FREEZING | 2013 |
|
RU2530149C1 |
FROST PROTECTION SOLUTION FOR NUCLEAR BLOOD CELL FREEZING | 2011 |
|
RU2464991C1 |
SOLUTION FOR CELL SUSPENSIONS PRESERVATION | 2015 |
|
RU2621295C2 |
CRYOCONSERVING AGENT FOR LEUCOCYTES | 2006 |
|
RU2301524C1 |
COLD-SAFETY SOLUTION FOR FREEZING PLATELETS AT MODERATELY LOW TEMPERATURE | 2002 |
|
RU2230454C2 |
Authors
Dates
2025-04-01—Published
2024-07-16—Filed